Since Vitamin D's anti-fibrotic effect depends on VDR genotypes and levels, polymorphisms in VDRs can also explain the inconsistent association of NAFLD with Vitamin D levels [18]. The gene discussed is VDR; the disease is metabolic dysfunction-associated steatotic liver disease.